Spero’s is developing a pipeline of drugs that treat both Gram-negative and Gram-positive bacteria, fungi and protists. Its platform, called the Potentiator, is essentially a combination therapeutics ...
Spero Therapeutics said today it was won a $1.65 million award from the U.S. Department of Defense (DoD) toward developing its anti-infective Potentiator program and advancing the best candidates ...
Respirerx Pharmaceuticals Inc.’s lead GABA-A receptor potentiator, KRM-II-81, has advanced to the next level of evaluation within the National Institutes of Health (NIH) HEAL Initiative Preclinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results